Literature DB >> 23978491

The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.

Patricia Amé-Thomas1, Karin Tarte2.   

Abstract

Follicular lymphoma (FL) results from the malignant transformation of germinal center B cells and is characterized by recurrent genetic alterations providing a direct growth advantage or facilitating interaction with tumor microenvironment. In agreement, accumulating evidences suggest a dynamic bidirectional crosstalk between FL B cells and surrounding non-malignant cells within specialized tumor niches in both invaded lymph nodes and bone marrow. Infiltrating stromal cells, macrophages, and T/NK cell subsets either contribute to anti-tumor immune response, or conversely form a tumor supportive network promoting FL B cell survival, growth, and drug resistance. This review depicts the phenotypic heterogeneity and functional plasticity of the most important FL cell partners and describes their complex interplay. We also unravel how malignant B cells recruit and subvert accessory immune and stromal cells to trigger their polarization toward a supportive phenotype. Based on these observations, innovative therapeutic approaches have been recently proposed, in order to benefit from local anti-tumor immunity and/or to selectively target the protective cell niche.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell interactions; Follicular helper T cells; Follicular lymphoma; Macrophages; Stromal cells

Mesh:

Year:  2013        PMID: 23978491     DOI: 10.1016/j.semcancer.2013.08.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  32 in total

Review 1.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

2.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

Review 3.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

Review 4.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Authors:  Patricia Amé-Thomas; Sylvia Hoeller; Catherine Artchounin; Jan Misiak; Mounia Sabrina Braza; Rachel Jean; Jérôme Le Priol; Céline Monvoisin; Nadine Martin; Philippe Gaulard; Karin Tarte
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

6.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

7.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

Review 8.  B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.

Authors:  G Galletti; F Caligaris-Cappio; M T S Bertilaccio
Journal:  Leukemia       Date:  2016-09-28       Impact factor: 11.528

9.  Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

Authors:  Claire Germain; Thierry Guillaudeux; Elisabeth D Galsgaard; Catherine Hervouet; Nedra Tekaya; Anne-Sophie Gallouet; Julien Fassy; Franck Bihl; Gwenola Poupon; Anne Lazzari; Pieter Spee; Fabienne Anjuère; Céline Pangault; Karin Tarte; Patrick Tas; Luc Xerri; Veronique M Braud
Journal:  Oncoimmunology       Date:  2015-04-08       Impact factor: 8.110

10.  A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent Lymphoma.

Authors:  Carol S Portlock; Paul A Hamlin; John F Gerecitano; Ariela Noy; Maria Lia Palomba; Janelle Walkley; Stacie Corcoran; Jocelyn Migliacci; Heiko Schoder; Genovefa Papanicolaou; Arnold J Markowitz
Journal:  Tumor Microenviron Ther       Date:  2015-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.